Our impact

The NIHR Birmingham Biomedical Research Centre has delivered substantial growth in research excellence, capacity and reach. Our multi-ethnic patient populations have enabled clinical research for patient benefit that reflects local and global diversity, maximising impact and value. We have delivered outstanding value for money as evidenced by the volume and quality of publications produced and by the return of £7 in leveraged income for every £1 NIHR have invested in the BRC.

Female researcher working in lab

We have published over 1,000 peer-reviewed articles.

Our impact: video series

Case studies

Why are ATMPs important?

Advanced Therapy Medicinal Products (ATMPs), which can be cell or gene therapies, show great potential in

Reducing liver transplant waiting lists

The increased need for transplantation is widely recognised, as emphasised by National Health Service Blood and

Maximising patient reported outcomes in clinical trials

Patient-reported outcomes (PROs) are used in thousands of clinical trials worldwide to provide evidence of efficacy,

Endoscopic imaging for inflammatory bowel disease

Gastrointestinal examination using an endoscope to look inside the body at abnormal tissue growth and inflammation

Ultrasound analysis detection of sarcopenia

Despite its common occurrence and impact on patients, sarcopenia (a muscle wasting syndrome) is not routinely

Home-based intervention to reduce sarcopenia

It is already well established in age-related sarcopenia (a muscle wasting syndrome) that resistance exercise can

Two researchers discussing

We have secured over £70 million of research income.

Established research leadership

The NIHR Birmingham Biomedical Research Centre team have been at the international forefront of inflammation research for many years as demonstrated by our research outputs and our leadership of several national/regional centres.

There are currently more than 300 BRC-linked researchers pursuing over 850 research projects funded by the EU, Medical Research Council and Innovate UK, as well as charities including Cancer Research UK and the Wellcome Trust.